Unknown

Dataset Information

0

Drug-target binding quantitatively predicts optimal antibiotic dose levels in quinolones.


ABSTRACT: Antibiotic resistance is rising and we urgently need to gain a better quantitative understanding of how antibiotics act, which in turn would also speed up the development of new antibiotics. Here, we describe a computational model (COMBAT-COmputational Model of Bacterial Antibiotic Target-binding) that can quantitatively predict antibiotic dose-response relationships. Our goal is dual: We address a fundamental biological question and investigate how drug-target binding shapes antibiotic action. We also create a tool that can predict antibiotic efficacy a priori. COMBAT requires measurable biochemical parameters of drug-target interaction and can be directly fitted to time-kill curves. As a proof-of-concept, we first investigate the utility of COMBAT with antibiotics belonging to the widely used quinolone class. COMBAT can predict antibiotic efficacy in clinical isolates for quinolones from drug affinity (R2>0.9). To further challenge our approach, we also do the reverse: estimate the magnitude of changes in drug-target binding based on antibiotic dose-response curves. We overexpress target molecules to infer changes in antibiotic-target binding from changes in antimicrobial efficacy of ciprofloxacin with 92-94% accuracy. To test the generality of our approach, we use the beta-lactam ampicillin to predict target molecule occupancy at MIC from antimicrobial action with 90% accuracy. Finally, we apply COMBAT to predict antibiotic concentrations that can select for resistance due to novel resistance mutations. Using ciprofloxacin and ampicillin as well defined test cases, our work demonstrates that drug-target binding is a major predictor of bacterial responses to antibiotics. This is surprising because antibiotic action involves many additional effects downstream of drug-target binding. In addition, COMBAT provides a framework to inform optimal antibiotic dose levels that maximize efficacy and minimize the rise of resistant mutants.

SUBMITTER: Clarelli F 

PROVIDER: S-EPMC7449454 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Drug-target binding quantitatively predicts optimal antibiotic dose levels in quinolones.

Clarelli Fabrizio F   Palmer Adam A   Singh Bhupender B   Storflor Merete M   Lauksund Silje S   Cohen Ted T   Abel Sören S   Abel Zur Wiesch Pia P  

PLoS computational biology 20200814 8


Antibiotic resistance is rising and we urgently need to gain a better quantitative understanding of how antibiotics act, which in turn would also speed up the development of new antibiotics. Here, we describe a computational model (COMBAT-COmputational Model of Bacterial Antibiotic Target-binding) that can quantitatively predict antibiotic dose-response relationships. Our goal is dual: We address a fundamental biological question and investigate how drug-target binding shapes antibiotic action.  ...[more]

Similar Datasets

| S-EPMC3528629 | biostudies-literature
| S-EPMC5306109 | biostudies-literature
| S-EPMC7730664 | biostudies-literature
| S-EPMC7135267 | biostudies-literature
| S-SCDT-MSB-2021-10767 | biostudies-other
| S-EPMC5570205 | biostudies-literature
| S-EPMC7150629 | biostudies-literature
| S-EPMC6129291 | biostudies-literature
| S-EPMC9315932 | biostudies-literature
| S-EPMC7499191 | biostudies-literature